CamDiab and Ypsomed announced that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system to help lessen the burden...
Abbott, known for its continuous glucose monitor (CGM) devices, is moving into making general purpose consumer biosensing wearables. In a healthtech keynote at the...
Supersapiens has announced a new wearable device specifically designed for athletes. Dubbed the Energy Band, the wearable, in conjunction with Abbott’s Libre Sense Glucose...
The newest trend to hit the wearables market is metabolic monitoring, which comes in the form of continuous glucose monitoring (CGM) devices. CGM tracks...